NCT00069888View on ClinicalTrials.gov

A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy

PHASE2CompletedINTERVENTIONAL

Enrollment

83

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Prostate Cancer

Interventions

DRUG

Docetaxel

Trial Locations (1)

08807

Sanofi-Aventis US, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY